4 Results
Guidelines and Advice
Status: Current
ID: 11-6
Version: 2
ID: 11-6
Version: 2
Feb 2022
Guidelines and Advice
Status: Current
ID: GL 9-11
ID: GL 9-11
Oct 2024
Drug
May 2022
Statistical Reports
Nov 2022